Annual Total Liabilities
$1.09 B
+$278.21 M+34.26%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual total liabilities is $1.09 billion, with the most recent change of +$278.21 million (+34.26%) on December 31, 2023.
- During the last 3 years, IBRX annual total liabilities has risen by +$750.52 million (+220.82%).
- IBRX annual total liabilities is now at all-time high.
Performance
IBRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.11 B
-$32.97 M-2.89%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly total liabilities is $1.11 billion, with the most recent change of -$32.97 million (-2.89%) on September 30, 2024.
- Over the past year, IBRX quarterly total liabilities has dropped by -$32.97 million (-2.89%).
- IBRX quarterly total liabilities is now -2.89% below its all-time high of $1.14 billion, reached on June 30, 2024.
Performance
IBRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
IBRX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.3% | -2.9% |
| 3 y3 years | +220.8% | +18.4% |
| 5 y5 years | - | +18.4% |
IBRX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +53.0% | -2.9% | +55.5% |
| 5 y | 5-year | at high | +220.8% | -2.9% | +226.2% |
| alltime | all time | at high | +220.8% | -2.9% | +226.2% |
ImmunityBio Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.11 B(-2.9%) |
| Jun 2024 | - | $1.14 B(+4.6%) |
| Mar 2024 | - | $1.09 B(+0.1%) |
| Dec 2023 | $1.09 B(+34.3%) | $1.09 B(+29.3%) |
| Sep 2023 | - | $843.06 M(-10.0%) |
| Jun 2023 | - | $936.41 M(+7.0%) |
| Mar 2023 | - | $875.12 M(+7.7%) |
| Dec 2022 | $812.18 M | $812.18 M(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $782.02 M(+5.7%) |
| Jun 2022 | - | $739.69 M(+1.7%) |
| Mar 2022 | - | $727.14 M(+2.0%) |
| Dec 2021 | $712.82 M(+109.7%) | $712.82 M(+76.3%) |
| Sep 2021 | - | $404.37 M(-0.1%) |
| Jun 2021 | - | $404.89 M(+2.6%) |
| Mar 2021 | - | $394.76 M(+16.2%) |
| Dec 2020 | $339.87 M | $339.87 M |
FAQ
- What is ImmunityBio annual total liabilities?
- What is the all time high annual total liabilities for ImmunityBio?
- What is ImmunityBio annual total liabilities year-on-year change?
- What is ImmunityBio quarterly total liabilities?
- What is the all time high quarterly total liabilities for ImmunityBio?
- What is ImmunityBio quarterly total liabilities year-on-year change?
What is ImmunityBio annual total liabilities?
The current annual total liabilities of IBRX is $1.09 B
What is the all time high annual total liabilities for ImmunityBio?
ImmunityBio all-time high annual total liabilities is $1.09 B
What is ImmunityBio annual total liabilities year-on-year change?
Over the past year, IBRX annual total liabilities has changed by +$278.21 M (+34.26%)
What is ImmunityBio quarterly total liabilities?
The current quarterly total liabilities of IBRX is $1.11 B
What is the all time high quarterly total liabilities for ImmunityBio?
ImmunityBio all-time high quarterly total liabilities is $1.14 B
What is ImmunityBio quarterly total liabilities year-on-year change?
Over the past year, IBRX quarterly total liabilities has changed by -$32.97 M (-2.89%)